Literature DB >> 20016026

Nanoparticles and the immune system.

Banu S Zolnik1, Africa González-Fernández, Nakissa Sadrieh, Marina A Dobrovolskaia.   

Abstract

Today nanotechnology is finding growing applications in industry, biology, and medicine. The clear benefits of using nanosized products in various biological and medical applications are often challenged by concerns about the lack of adequate data regarding their toxicity. One area of interest involves the interactions between nanoparticles and the components of the immune system. Nanoparticles can be engineered to either avoid immune system recognition or specifically inhibit or enhance the immune responses. We review herein reported observations on nanoparticle-mediated immunostimulation and immunosuppression, focusing on possible theories regarding how manipulation of particle physicochemical properties can influence their interaction with immune cells to attain desirable immunomodulation and avoid undesirable immunotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016026      PMCID: PMC2817614          DOI: 10.1210/en.2009-1082

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  74 in total

Review 1.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Authors:  Jayanth Panyam; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2003-02-24       Impact factor: 15.470

2.  Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.

Authors:  Theodora Fifis; Anita Gamvrellis; Blessing Crimeen-Irwin; Geoffrey A Pietersz; Jie Li; Patricia L Mottram; Ian F C McKenzie; Magdalena Plebanski
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

3.  Effect of ionizing radiation on thymic epithelial cell function. I. Radiation-spared thymic epithelial grafts expedite the recovery of T cell function in lethally irradiated and fetal liver reconstituted mice.

Authors:  S E Wiedmeier; W E Samlowski; C J Rasmussen; K Huang; R A Daynes
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

4.  Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies.

Authors:  J Szebeni; L Baranyi; S Savay; J Milosevits; R Bunger; P Laverman; J M Metselaar; G Storm; A Chanan-Khan; L Liebes; F M Muggia; R Cohen; Y Barenholz; C R Alving
Journal:  J Liposome Res       Date:  2002 Feb-May       Impact factor: 3.648

5.  Prevention of acute lung injury in swine: depletion of pulmonary intravascular macrophages using liposomal clodronate.

Authors:  Jeffrey G Gaca; Daniel Palestrant; Daniel J Lukes; Michael Olausson; William Parker; R Duane Davis
Journal:  J Surg Res       Date:  2003-06-01       Impact factor: 2.192

6.  Biochemical and immunological properties of cytokines conjugated to dendritic polymers.

Authors:  S C Lee; R Parthasarathy; K Botwin; D Kunneman; E Rowold; G Lange; J Klover; A Abegg; J Zobel; T Beck; T Miller; W Hood; J Monahan; J P McKearn; R Jansson; C F Voliva
Journal:  Biomed Microdevices       Date:  2004-09       Impact factor: 2.838

7.  Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.

Authors:  A Chanan-Khan; J Szebeni; S Savay; L Liebes; N M Rafique; C R Alving; F M Muggia
Journal:  Ann Oncol       Date:  2003-09       Impact factor: 32.976

8.  Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers.

Authors:  S M Moghimi
Journal:  Biochim Biophys Acta       Date:  2002-06-12

9.  Effect of cadmium on lymphocyte subsets distribution in thymus and spleen.

Authors:  A Lafuente; A González-Carracedo; A Romero; A I Esquifino
Journal:  J Physiol Biochem       Date:  2003-03       Impact factor: 4.158

10.  Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model.

Authors:  I Schöll; A Weissenböck; E Förster-Waldl; E Untersmayr; F Walter; M Willheim; G Boltz-Nitulescu; O Scheiner; F Gabor; E Jensen-Jarolim
Journal:  Clin Exp Allergy       Date:  2004-02       Impact factor: 5.018

View more
  189 in total

Review 1.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

2.  Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapy.

Authors:  Maria Aurora Grimaudo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium.

Authors:  Poornima Kolhar; Aaron C Anselmo; Vivek Gupta; Kapil Pant; Balabhaskar Prabhakarpandian; Erkki Ruoslahti; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

4.  The type of adjuvant strongly influences the T-cell response during nanoparticle-based immunization.

Authors:  Torben Knuschke; Matthias Epple; Astrid M Westendorf
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452

Review 5.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

6.  Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications.

Authors:  Wanji Seo; Alexandr A Kapralov; Galina V Shurin; Michael R Shurin; Valerian E Kagan; Alexander Star
Journal:  Nanoscale       Date:  2015-05-21       Impact factor: 7.790

Review 7.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

Review 8.  From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune system.

Authors:  Matthew J Smith; Jared M Brown; William C Zamboni; Nigel J Walker
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

Review 9.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

10.  Multilayered inorganic-organic microdisks as ideal carriers for high magnetothermal actuation: assembling ferrimagnetic nanoparticles devoid of dipolar interactions.

Authors:  Idoia Castellanos-Rubio; Rahul Munshi; Yueling Qin; David B Eason; Iñaki Orue; Maite Insausti; Arnd Pralle
Journal:  Nanoscale       Date:  2018-11-29       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.